Skip to main content
. Author manuscript; available in PMC: 2017 Aug 30.
Published in final edited form as: Cardiol Young. 2014 Jan 29;25(2):355–357. doi: 10.1017/S1047951114000067

Figure 1.

Figure 1

(a, b): Four-chamber (a) and three-chamber (b) bright blood cardiac magnetic resonance imaging at age 22 showing asymmetric septal hypertrophy. (c): Short-axis post-contrast imaging at age 22 showing diffuse sub-epicardial left ventricular free wall late gadolinium enhancement (green arrows) and multiple focal septal areas of mid-myocardial late gadolinium enhancement (red arrows). (d): Short-axis post-contrast imaging at age 27 showing progression of sub-epicardial left ventricular free wall enhancement (green arrows) and progression in terms of both number and thickness of focal areas of mid-myocardial septal enhancement (red arrows).

HHS Vulnerability Disclosure